Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The International Journal of Neuropsychopharmacology

Topics

Economics

Pathology

Medicine

Internal Medicine

Pharmacology

Show all topics

DOI

10.1093/ijnp/pyz039

License

CC-BY-NC

Other Formats

PDF